Testudinid herpesviruses (TeHVs) and ranaviruses are important pathogens of tortoises, but no treatments are available. Lysine may inhibit herpesvirus (HV) replication, although its effectivity has been questioned. Lactoferrin has antiviral activity against a range of viruses by inhibiting adsorption to cells. Media were supplemented with 6.25–10 mg/ml lysine and 0.625–1 mg/ml lactoferrin, individually or combined, and the effects measured against the replication of TeHV-1, TeHV-3, or a ranavirus in Terrapene heart cells (TH-1). Cytotoxicity testing was also carried out with the same concentrations. Lysine alone inhibited cell growth after 24 and 48 h, whereas lactoferrin only reduced cell growth after 24 h. TeHV-1 titers were only reduced by the addition of a combination of 10 mg/ml lysine and 1 mg/ml lactoferrin after 48 h (43.8% reduction) and by 10 mg/ml lysine (82.2% reduction). The same concentration of the combined substances led to an average reduction in TeHV-3 titers of 43.8% after 24 h and 68.4% after 48 h, respectively, while 10 mg/ml lysine led to an average reduction of 92.5% after 48 h. Lactoferrin alone did not reduce HV titers. Both concentrations of the combined substances led to titer reductions of the ranavirus (86.7–96.8%), and testing of the individual substances led to a reduction of 97.6% after 48 h with 10 mg/ml lysine and of 82.2% after 24 h with 1 mg/ml lactoferrin.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.